Optimal fixation of cells for use in solid-phase ELISA.

Area of Science:

• Biotechnology
• Immunological Assays
• Cell Biology

Background:

• Glutaraldehyde (GA) is a common cross-linking agent for fixing cells in microtitre plates for immunoassays.
• High GA concentrations can lead to increased non-specific antibody binding, compromising assay specificity.
• Optimizing GA concentration is crucial for stable cell fixation while minimizing assay interference.

Purpose of the Study:

• To determine the optimal glutaraldehyde (GA) concentration for stable whole-cell fixation in solid-phase ELISA.
• To investigate the impact of GA concentration on non-specific antibody binding.
• To assess the influence of microtitre plate type and cell characteristics on cell fixation variability.

Main Methods:

• Whole cells were fixed onto microtitre plates using varying concentrations of glutaraldehyde (GA).
• Enzyme-linked immunosorbent assays (ELISA) were performed to measure antibody binding.
• Non-specific antibody binding levels were quantified at different GA concentrations.
• Cell fixation efficiency and variability were assessed across different plate types and cell lines.

Main Results:

• Glutaraldehyde (GA) concentrations above 0.10% (v/v) significantly increased non-specific antibody binding in ELISA.
• Optimal cell fixation with minimal non-specific binding was achieved using 0.05-0.025% (v/v) GA.
• Significant variability in cell binding to microtitre plates was observed, influenced by plate material and cell type.

Conclusions:

• Using lower glutaraldehyde (GA) concentrations (0.05-0.025%) is recommended for stable whole-cell fixation in solid-phase ELISA.
• This concentration range effectively minimizes non-specific antibody binding, enhancing assay reliability.
• Assay developers must consider microtitre plate type and cell characteristics to account for fixation variability.